INCY vs MRNA
Incyte Corporation · Moderna, Inc.
Relative return (rebased to 100)
Key stats
| Metric | INCY | MRNA |
|---|---|---|
| Price | $119.65 | $254.19 |
| Market Cap | $24.39B | $102.85B |
| P/E | 18.96 | — |
| P/B | 4.32 | 15.04 |
| P/S | 4.74 | 52.91 |
| ROE | 22.8% | -41.3% |
| Net Margin | 25.0% | -145.2% |
| Gross Margin | — | — |
| Revenue Growth | 21.2% | -39.9% |
| Dividend Yield | — | — |
| EPS | $6.31 | -$6.97 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.